National Cancer Center Hospital ( Site 0201) — Chūō, Tokyo

Public research footprint of National Cancer Center Hospital ( Site 0201), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Breast Neoplasms · Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis… · Lymphoma, Large B-Cell, Diffuse

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT06966700 — A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast… (Recruiting)
NCT07209111 — A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at National Cancer Center Hospital ( Site 0201)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.